SK life science, a subsidiary of SK biopharmaceuticals, has focused its efforts on research and development in CNS disorders since 1993. We are a part of SK Group, a global conglomerate and the second largest company in Korea. In the US, we are transitioning from a clinical-stage company to a fully-integrated pharmaceutical organization. SK life science has two CNS products in late stage development.
First Time Exhibitor No